Geneva — The World Health Organization (WHO) said on Tuesday it has approved a Covid-19 vaccine made by drugmaker Sinovac Biotech for emergency-use listing, paving the way for a second Chinese shot to be used in poor countries.
A WHO emergency listing is a signal to national regulators on a product’s safety and efficacy. It will also allow the shot to be included in Covax, the global programme to provide vaccines mainly for poor countries, which faces major supply problems due to an Indian export suspension...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.